Genetic risk stratification and outcomes among treatment-naive patients with AML treated with venetoclax and azacitidine. Dohner H, Pratz KW, DiNardo CD, Wei AH, et al. Blood 2024;144:2211-2222.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Dohner H, Pratz KW, DiNardo CD, Wei AH, et al. Genetic risk stratification and outcomes among treatment-naive patients with AML treated with venetoclax and azacitidine. Blood 2024;144:2211-2222.
PMID: 39133921